Skip to main content
Contact Us
Subscribe
E-Edition
42°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edgewise Therapeutics Inc
(NQ:
EWTX
)
17.96
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
17.96
Bid (Size)
17.32 (1)
Ask (Size)
18.71 (1)
Prev. Close
17.96
Today's Range
17.96 - 17.96
52wk Range
5.120 - 20.69
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Edgewise Therapeutics Announces Upcoming Podium Presentation at the American College of Cardiology's 2024 Annual Scientific Session
Today 8:00 EDT
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium on April 2, 2024
March 27, 2024
From
Edgewise Therapeutics
Via
Business Wire
Performance
YTD
+63.27%
+63.27%
1 Month
+5.40%
+5.40%
3 Month
+48.43%
+48.43%
6 Month
+194.43%
+194.43%
1 Year
+156.57%
+156.57%
More News
Read More
Edgewise Therapeutics to Present at the Leerink Partners Global Biopharma Conference on March 11, 2024
March 05, 2024
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
How Is The Market Feeling About Edgewise Therapeutics?
January 31, 2024
Via
Benzinga
Edgewise Therapeutics: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
Edgewise Therapeutics to Present on EDG-5506 for the Treatment of Becker Muscular Dystrophy at the 2024 MDA Clinical and Scientific Conference
February 28, 2024
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
February 22, 2024
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne)
February 13, 2024
From
Edgewise Therapeutics
Via
Business Wire
Insider Favorites: 7 Stocks with Bullish Buying Signals
February 11, 2024
Via
InvestorPlace
Insiders Buying Edgewise Therapeutics And 2 Other Stocks
January 26, 2024
Via
Benzinga
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 19, 2024
Via
Benzinga
What's Going On With Edgewise Therapeutics Stock?
January 19, 2024
Via
Benzinga
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
January 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Edgewise Therapeutics Announces Pricing of $240 Million Underwritten Offering of Common Stock
January 19, 2024
From
Edgewise Therapeutics
Via
Business Wire
3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street
January 16, 2024
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
January 11, 2024
Via
Benzinga
Edgewise Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
January 09, 2024
From
Edgewise Therapeutics
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 27, 2023
Via
Benzinga
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 27, 2023
Via
Benzinga
Edgewise Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
December 19, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Launches First of Its Kind Educational Website Dedicated to the Becker Muscular Dystrophy Community
December 18, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Receives Orphan Drug and Rare Pediatric Disease Designations for Its Muscular Dystrophy Program from FDA
November 30, 2023
From
Edgewise Therapeutics
Via
Business Wire
Speculator’s Watch List: 7 Stocks Ripe for a Short-Squeeze Windfall
November 28, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.